The Journal of Antibiotics · 1986 · 23 citations · 28 references
MedicineMedicinal ChemistryDrug DiscoveryAntibacterial AgentsAntibacterial PharmacologyAntimicrobial MetabolitesBeta-lactamase InhibitorsNovel Antibacterial AgentsSpectrum Of Beta-lactam Antibioticsβ-Lactam Antibiotics
The synthesis and the relationship between in vitro and in vivo activities of 6-[(R)-2-[3-(3,4-dihydroxybenzoyl)-3-R1-1-ureido]-2- phenylacetamido]penicillanic acids having C2 approximately 8 alkyl or substituted alkyl groups as the substituents (R1) are described. In this series, 6-[(R)-2-[3-(3,4-dihydroxybenzoyl)-3-(3-hydroxypropyl)-1-ureido] -2-phenylacetamido]penicillanic acid (1b, AO-1100) showed the most potent protective effect on mice in experimental Pseudomonas aeruginosa infections, although it did not have the strongest in vitro activity among the penicillins we synthesized.
28